From: Investor's Business Daily<ibd@ibd1.investors.com>
To: david@coronariversidehomes.com
Received: Tuesday, May 19, 2009 02:50 AM
IBD Tech Report Newsletter
Discover emerging trends and the companies driving them with IBD Tech Report View IBD Tech Report as a web page | Please add ibd@ibd1.investors.com to your address book.
Capital always flows to where there is productivity, efficiency and innovation — where you can get better returns... U.S. and European companies will have to find the means and the areas where they have a competitive advantage.
Cymer (CYMI) and other semiconductor capital equipment companies were raised to buy from hold by Stifel Nicolaus, which cited a sharp reduction in semiconductor inventory levels that could lead to an undersupply situation in the next upturn. Stifel also said increasing chipmaker utilization rates should eventually spur new equipment capacity buys. Novellus (NVLS) and Teradyne (TER) were among the companies upgraded. Cymer gained 8.8% as Novellus and Teradyne each rose over 5%.
The information contained herein is not and should not be construed as a solicitation to buy or sell any securities. Legal Disclaimer
Do not reply to this message, as it will not be received. For further assistance or to contact IBD, please visit www.investors.com. To update your email communication preferences click here.
You received this e-mail because you are currently subscribed to the Tech Report e-mail from Investor's Business Daily. Click here to unsubscribe.
Investor's Business Daily, IBD and CAN SLIM and their corresponding logos are registered trademarks of Data Analysis, Inc., an affiliate of Investor's Business Daily. Copyright and Trademark Notice.
